Growth Metrics

Organogenesis Holdings (ORGO) Long-Term Deferred Tax (2017 - 2025)

Historic Long-Term Deferred Tax for Organogenesis Holdings (ORGO) over the last 9 years, with Q3 2025 value amounting to $45.6 million.

  • Organogenesis Holdings' Long-Term Deferred Tax rose 2703.34% to $45.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $45.6 million, marking a year-over-year increase of 2703.34%. This contributed to the annual value of $39.5 million for FY2024, which is 4092.56% up from last year.
  • As of Q3 2025, Organogenesis Holdings' Long-Term Deferred Tax stood at $45.6 million, which was up 2703.34% from $41.8 million recorded in Q2 2025.
  • In the past 5 years, Organogenesis Holdings' Long-Term Deferred Tax registered a high of $45.6 million during Q3 2025, and its lowest value of $18000.0 during Q1 2021.
  • Its 5-year average for Long-Term Deferred Tax is $28.5 million, with a median of $32.0 million in 2021.
  • As far as peak fluctuations go, Organogenesis Holdings' Long-Term Deferred Tax surged by 17764444.44% in 2021, and later crashed by 670.35% in 2023.
  • Quarter analysis of 5 years shows Organogenesis Holdings' Long-Term Deferred Tax stood at $32.0 million in 2021, then dropped by 6.19% to $30.0 million in 2022, then decreased by 6.7% to $28.0 million in 2023, then skyrocketed by 40.93% to $39.5 million in 2024, then grew by 15.53% to $45.6 million in 2025.
  • Its Long-Term Deferred Tax was $45.6 million in Q3 2025, compared to $41.8 million in Q2 2025 and $40.7 million in Q1 2025.